Literature DB >> 19065605

Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver.

Chul-Hee Kim1, Joong-Yeol Park, Ki-Up Lee, Jin-Ho Kim, Hong-Kyu Kim.   

Abstract

BACKGROUND: Although elevated serum concentrations of gamma-glutamyltrans- ferase (GGT) or alanine aminotransferase (ALT) have been associated with type 2 diabetes mellitus, it is unclear whether each is an independent predictor of type 2 diabetes or merely a surrogate marker for fatty liver or hepatic injury.
METHODS: We assessed clinical and laboratory findings in 3556 non-diabetic subjects (2217 men, 1339 women; age, 45.7 +/- 8.1 (range 20-79) years) without fatty liver or clinically significant hepatic dysfunction who underwent voluntary medical check-ups at a 5-year interval.
RESULTS: The odds ratio of developing type 2 diabetes increased significantly with increasing GGT and ALT levels at baseline. In multiple logistic regression models adjusted for age, sex, alcohol consumption, smoking, body mass index (BMI), triglycerides, high-density lipoprotein (HDL)-cholesterol, fasting glucose, and ALT, the highest quartile of GGT remained significantly associated with type 2 diabetes. Compared with the first GGT quartile, the odds ratios of the second, third, and fourth GGT quartiles were 0.64 (95% CI, 0.25-1.65), 1.12 (0.45-2.78), and 3.07 (1.21-7.76), respectively. The adjusted odds ratios for the second, third, and fourth ALT quartiles in the same logistic regression model were 2.40 (0.83-6.94), 2.85 (1.03-7.90), and 4.31 (1.56-11.88), respectively. The risk of type 2 diabetes was additive with respect to GGT and ALT quartiles.
CONCLUSIONS: Increased serum GGT and ALT levels are independent, additive risk factors for the development of type 2 diabetes mellitus in subjects without fatty liver or hepatic dysfunction. Copyright 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19065605     DOI: 10.1002/dmrr.890

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  21 in total

1.  Associations of Early to Mid-Childhood Adiposity with Elevated Mid-Childhood Alanine Aminotransferase Levels in the Project Viva Cohort.

Authors:  Jennifer A Woo Baidal; Erin E Elbel; Joel E Lavine; Sheryl L Rifas-Shiman; Matthew W Gillman; Emily Oken; Elsie M Taveras
Journal:  J Pediatr       Date:  2018-04-04       Impact factor: 4.406

2.  Oleanolic acid derivative DKS26 exerts antidiabetic and hepatoprotective effects in diabetic mice and promotes glucagon-like peptide-1 secretion and expression in intestinal cells.

Authors:  Fei-Fei Chen; Jian-Ta Wang; Li-Xia Zhang; Shu-Fang Xing; Yun-Xia Wang; Kai Wang; Shu-Li Deng; Ji-Quan Zhang; Lei Tang; Hao-Shu Wu
Journal:  Br J Pharmacol       Date:  2017-07-26       Impact factor: 8.739

3.  Increased liver markers are associated with higher risk of type 2 diabetes.

Authors:  Sun-Hye Ko; Myong Ki Baeg; Kyung-Do Han; Seung-Hyun Ko; Yu-Bae Ahn
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

4.  Self-reported rate of eating is associated with higher circulating ALT activity in middle-aged apparently healthy Japanese men.

Authors:  Kazuki Mochizuki; Rie Miyauchi; Natsuyo Hariya; Yasumi Misaki; Nobuhiko Kasezawa; Kazushige Tohyama; Toshinao Goda
Journal:  Eur J Nutr       Date:  2012-07-03       Impact factor: 5.614

5.  Association of vitamin E intake at early childhood with alanine aminotransferase levels at mid-childhood.

Authors:  Jennifer A Woo Baidal; Erika R Cheng; Sheryl L Rifas-Shiman; Emily Oken; Matthew W Gillman; Elsie M Taveras
Journal:  Hepatology       Date:  2018-03-01       Impact factor: 17.425

6.  Risk factors for incident type 2 diabetes in individuals with a BMI of <27 kg/m2: the role of gamma-glutamyltransferase. Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).

Authors:  A Gautier; B Balkau; C Lange; J Tichet; F Bonnet
Journal:  Diabetologia       Date:  2009-11-20       Impact factor: 10.122

7.  Elevated alanine aminotransferase activity is not associated with dyslipidemias, but related to insulin resistance and higher disease grades in non-diabetic non-alcoholic fatty liver disease.

Authors:  Mohammad Ebrahim Ghamar-Chehreh; Mohsen Amini; Hossein Khedmat; Seyed Moayed Alavian; Fatemeh Daraei; Reza Mohtashami; Reza Hadi; Bent-Al-Hoda Beyram; Saeed Taheri
Journal:  Asian Pac J Trop Biomed       Date:  2012-09

8.  Relationship between gamma-glutamyl transferase and glucose intolerance in first degree relatives of type 2 diabetics patients.

Authors:  Sassan Haghighi; Massoud Amini; Zahra Pournaghshband; Peyvand Amini; Silva Hovsepian
Journal:  J Res Med Sci       Date:  2011-02       Impact factor: 1.852

9.  Association of serum alanine aminotransferase and γ-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease.

Authors:  Hyo Jeong Oh; Tae Hyeon Kim; Young Woo Sohn; Yong Sung Kim; Yong Reol Oh; Eun Young Cho; So Yeon Shim; Sae Ron Shin; A Lum Han; Seok Jin Yoon; Haak Cheoul Kim
Journal:  Korean J Hepatol       Date:  2011-03

10.  Differential patterns of insulin secretion and sensitivity in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease versus patients with type 2 diabetes mellitus alone.

Authors:  Shang-Yu Chai; Xiao-Yu Pan; Ke-Xiu Song; Yue-Ye Huang; Fei Li; Xiao-Yun Cheng; Shen Qu
Journal:  Lipids Health Dis       Date:  2014-01-07       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.